Hongbo Ma

401 citations
21 papers · 258 indexed · h-index 8
Topics
Lung Cancer Treatments and Mutations (4 papers)Ferroptosis and cancer prognosis (3 papers)Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (2 papers)
Partner nations
ChinaJapanUnited States

In The Last Decade

Hongbo Ma

20 papers receiving 253 citations

Peers

Hongbo Ma
Comparison fields: 5 of 68
  • Pulmonary and Respiratory Medicine 144
  • Molecular Biology 83
  • Oncology 60
  • Cancer Research 49
  • Physiology 35
Replace Changsen Leng with:
Changsen Leng China
Dandan Zhu China
Zhenhong Zou China
Guido P. L. Bossers Netherlands
Veronika Sárosi Hungary
Ghada E. Esheba Egypt
Zi-Jian Lu China
Tadasuke Shimokawaji Japan
Suguru Maruyama Japan
Hongbo Ma relative to Changsen Leng China Changsen Leng's profile →
Citations per field
00.5×2.5×
Changsen Leng · 1×
Citations per year

Countries citing papers authored by Hongbo Ma

Since Specialization
Citations

This map shows the geographic impact of Hongbo Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hongbo Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hongbo Ma more than expected).

Fields of papers citing papers by Hongbo Ma

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hongbo Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hongbo Ma. The network helps show where Hongbo Ma may publish in the future.

Co-authorship network of co-authors of Hongbo Ma

This figure shows the co-authorship network connecting the top 25 collaborators of Hongbo Ma. A scholar is included among the top collaborators of Hongbo Ma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hongbo Ma. Hongbo Ma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 0
3 6
4 5
5 8
6 53
7 40
8 53
9 30
10 3
11 2
12 9
13 3
14 10
15 1
16 6
17 12
18
Association of ACE polymorphism and diabetic nephropathy susceptibility.
4
19 4
20
Effect of oral KTYX on blood glucose in human
1

About Hongbo Ma

Hongbo Ma is a scholar working on Pulmonary and Respiratory Medicine, Cancer Research and Oncology, having authored 21 papers that have together received 258 indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (4 papers), Ferroptosis and cancer prognosis (3 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (2 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (144 citations), Cancer Research (49 citations) and Oncology (60 citations). Hongbo Ma has collaborated with scholars based in China, Japan and United States. Frequent co-authors include Yong Xia, Yi Li, Fuyan Xu, Yiqian Zhang, Xuan Liu, Meng‐Ling Wu, Shengming Liu, Chengqi He, Yi Li and Anqi He. Their work appears in journals such as Cancer Letters, Medicine and Frontiers in Pharmacology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026